Publications

Publications

Article
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS Study.
Human Vaccines & Immunotherapeutics 2024; 20(1): 2350091.
Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Sato S, Kawazoe Y, Maeda M, Murata F, Fukuda H.
Effectiveness of BNT162b2 against infection, symptomatic infection, and hospitalization among older adults aged ≥65 years during the Delta variant predominance in Japan: The VENUS Study.
Journal of Epidemiology 2024; 34(6): 278-285.
Sato S, Kawazoe Y, Katsuta T, Fukuda H.
Comparison design and evaluation power in cohort and self- controlled case series designs for post-authorization vaccine safety studies.
PeerJ 2024; 12: e16780.
Murata F, Maeda M, Murayama K, Nakao T, Fukuda H.
Associations between COVID-19 vaccination and incident psychiatric disorders after breakthrough SARS-CoV-2 infection: The VENUS Study.
Brain Behavior and Immunity 2024; 117: 521-528.
Murata F, Maeda M, Ono R, Fukuda H.
Association Between Regular Physical Activity and Pneumonia-Related Hospitalization According to Pneumococcal Vaccination Status: The VENUS Study.
Vaccine 2024; 42(6): 1268-1274.
Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H.
Bivalent mRNA Vaccine Effectiveness and Hybrid Immunity against COVID-19 among Older Adults in Japan: A Test-negative Study from the VENUS Study.
BMC Infectious Diseases 2024; 24(1): 135.
Yamada N, Nakatsuka K, Tezuka M, Murata F, Maeda M, Akisue T, Fukuda H, Ono R.
Pneumococcal vaccination coverage and vaccination-related factors among older adults in Japan: LIFE Study.
Vaccine 2024; 42(2): 239-245.
Sato S, Katsuta T, Kawazoe Y, Takahashi M, Murata F, Maeda M, Fukuda H, Kamidani S.
Immune thrombocytopenic purpura and Guillain-Barré syndrome after 23-valent pneumococcal polysaccharide vaccination in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
Vaccine 2024; 42(1): 4-7.
Mimura W, Ishiguro C, Terada-Hirashima J, Matsunaga N, Maeda M, Murata F, Fukuda H.
Bivalent vaccine effectiveness among older adults aged ≥65 years during the BA.5 predominant period in Japan: the VENUS Study.
Open Forum Infectious Diseases 2023; 10(10): ofad475.
Tsuzuki S, Murata F, Maeda M, Asai Y, Koizumi R, Ohmagari N, Fukuda H.
The association between seasonal influenza vaccination and antimicrobial use in Japan from the 2015-2016 to 2020-2021 seasons: from the VENUS study.
Journal of Antimicrobial Chemotherapy 2023; 78(12): 2976-2982.
More
Conference
川添百合香, 勝田友博, 田中敏博, 中村幸嗣, 佐藤俊太朗, 前田恵, 村田典子, 福田治久
10歳代のHPVワクチン非接種者におけるHPVワクチン接種後に報告された「多様な症状」と同症状の有訴率：VENUS Study.
第35回日本疫学会学術総会 2025年2月12日～14日. 高知
前田恵, 村田典子, 福田治久
おたふくかぜの疾病負荷およびワクチン接種率の推移：VENUS Study.
第35回日本疫学会学術総会2025年2月12日～14日. 高知
岡愛実子, 片岡葵, 中谷友樹, 上田豊, 前田恵, 村田典子, 伊藤ゆり, 片野田耕太, 福田治久
HPVワクチン累積接種割合の地域格差とその要因分析: VENUS Study.
第83回日本公衆衛生学会総会2024年10月29日-31日. 札幌
前田恵, 村田典子, 北村哲久, 福田治久
脳梗塞発症リスクにおけるインフルエンザワクチンの有効性評価：VENUS Study.
第28回日本ワクチン学会・第65回日本臨床ウイルス学会合同学術集会2024年10月26日-27日. 愛知
村田典子, 前田恵, 福田治久
レセプトデータベースを用いた帯状疱疹ワクチンの有効性検討：VENUS Study.
第28回日本ワクチン学会・第65回日本臨床ウイルス学会　合同学術集会2024年10月26日-27日. 愛知.
Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H.
Effectiveness of Maternal mRNA COVID-19 Vaccination Against COVID-19 Symptomatic Infection and Hospitalization in Infants Aged < 6 Months During the SARS-CoV-2 Omicron-Predominant Period: VENUS Study.
2024 ISPE Annual Meeting. 24-28 August 2024. Berlin, Germany.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Pilot study on the application of rapid cycle analysis method for post-marketing active vaccine safety surveillance using COVID-19 vaccines in Japan: the VENUS Study.
2024 ISPE Annual Meeting. 24-28 August 2024. Berlin, Germany.
村田典子, 前田恵, 福田治久.
肺炎球菌ワクチン接種有無別の死因分析：VENUS Study.
第98回日本感染症学会学術講演会・第72回日本化学療法学会総会合同学会. 2024年6月27日～29日. 神戸. [若手優秀演題]
Asai Y, Tsuzuki Y, Koizumi R, Murata F, Maeda M, Ohmagari N, Ishiguro C, Fukuda H.
COVID-19 pandemic encourages childhood vaccination in Japan: findings from the VENUS study.
34th ECCMID European Congress of Clinical Microbiology and Infectious Diseases. 2024年4月27日～30日, Barcelona, Spain.
玉田雄大, 塩田千尋, 竹内研時, 小坂健, 前田恵, 村田典子, 福田治久.
新型コロナウイルス2価ワクチン有効性の経時的変化：VENUS Study.
第94回日本衛生学会学術総会. 2024年3月7日-9日. 鹿児島.
More
Media
More